Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 3/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.46 |
| ▸ | CES1 | P23141 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.41 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29458360 | 1.00 | ACHE (0.53) | ACHENPC1RAB9ASMN1; SMN2PTGS2 | |
| SCHEMBL8021509 | 0.84 | ACHE (0.54) | ACHENPC1RAB9ASMN1; SMN2PTGS2 | |
| SCHEMBL11599168 | 0.83 | GAA (0.44) | ACHENPC1RAB9ASMN1; SMN2PTGS2 | |
| SCHEMBL856747 | 0.82 | ACHE (0.56) | ACHESMN1; SMN2KDM4EMAPTALDH1A1 | |
| SCHEMBL15912541 | 0.82 | ACHE (0.53) | ACHENPC1RAB9ASMN1; SMN2PTGS2 | |
| SCHEMBL578148 | 0.82 | ACHE (0.50) | ACHENPC1RAB9ASMN1; SMN2PTGS2 | |
| SCHEMBL30023013 | 0.82 | ACHE (0.50) | ACHENPC1RAB9ASMN1; SMN2PTGS2 | |
| SCHEMBL29458361 | 0.81 | HSD17B10 (0.60) | ACHENPC1RAB9ASMN1; SMN2PTGS2 | |
| SCHEMBL599658 | 0.81 | HSD17B10 (0.60) | ACHENPC1RAB9ASMN1; SMN2PTGS2 | |
| SCHEMBL346274 | 0.80 | ACHE (0.51) | ACHENPC1RAB9ASMN1; SMN2PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 313 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10858310-B1 | Method for producing isocyanates | COVERSTRO DEUTSCHLAND AG (DE) | 2020-12-08 | — | — | US | claimed |
| US-20200361856-A1 | METHOD FOR PRODUCING ISOCYANATES | COVESTRO DEUTSCHLAND AG (DE) | 2020-11-19 | — | — | US | claimed |
| CN-111250169-A | Preparation method and application of high-stability platinum complex catalyst | 东莞市晶瑞达硅胶材料科技有限公司 | 2020-06-09 | — | — | CN | claimed |
| CN-111051276-A | Method for producing isocyanates | 科思创德国股份有限公司 | 2020-04-21 | — | — | CN | claimed |
| US-20140213690-A1 | Titanium Containing Complex and Condensation Reaction Catalysts, Methods for Preparing the Catalysts, and Compositions Containing the Catalysts | DOW CORNING CORPORATION (US) | 2014-07-31 | — | — | US | claimed |
| US-20140213750-A1 | Hafnium Containing Complex and Condensation Reaction Catalysts, Methods for Preparing the Catalysts, and Compositions Containing the Catalysts | DOW CORNING CORPORATION | 2014-07-31 | — | — | US | claimed |
| CN-103781823-A | Titanium containing complex and condensation reaction catalysts, methods for preparing the catalysts, and compositions containing the catalysts | DOW CORNING | 2014-05-07 | — | — | CN | claimed |
| WO-2013036550-A1 | HAFNIUM CONTAINING COMPLEX AND CONDENSATION REACTION CATALYSTS, METHODS FOR PREPARING THE CATALYSTS, AND COMPOSITIONS CONTAINING THE CATALYSTS | DOW CORNING CORPORATION (US) | 2013-03-14 | — | — | WO | claimed |
| WO-2013036546-A2 | TITANIUM CONTAINING COMPLEX AND CONDENSATION REACTION CATALYSTS, METHODS FOR PREPARING THE CATALYSTS, AND COMPOSITIONS CONTAINING THE CATALYSTS | DOW CORNING CORPORATION (US) | 2013-03-14 | — | — | WO | claimed |
| EP-0916697-B1 | Hydrosilylation catalysts and silicone compositions using the same | SHINETSU CHEMICAL CO (JP) | 2002-09-04 | — | — | EP | claimed |
| US-5583242-A | VANADYL COMPLEXES | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-12-10 | — | — | US | claimed |
| EP-0743574-A2 | Migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| EP-0743573-A2 | Method for obtaining image contrast migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| US-5565491-A | FOR TREATMENT OF DISEASES MARKED BY MALIGNANT PROLIFERATION OF B CELLS, SUCH AS LEUKEMIA AND LYMPHOMAS; ANTICARCINOGENIC AGENTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-10-15 | — | — | US | claimed |
| US-5563014-A | SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT | XEROX CORPORATION (US) | 1996-10-08 | — | — | US | claimed |
| US-5514505-A | SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE | XEROX CORPORATION (US) | 1996-05-07 | — | — | US | claimed |
| EP-0108023-B1 | PROCESS FOR THE STABILIZATION OF VINYL CHLORIDE POLYMERS | RHONE-POULENC CHIMIE (FR) | 1986-12-17 | — | — | EP | claimed |
| US-4255319-A | PHOSPHINE INHIBITION; NONTOXIC; STORAGE STABILITY; MATERIALS HANDLING | UNION CARBIDE CORPORATION (US) | 1981-03-10 | — | — | US | claimed |
| US-4123399-A | B-DIKETONES, A POLYOL, AND AN ORGANO-METALLIC SALT | RHONE-POULENC INDUSTRIES (FR) | 1978-10-31 | — | — | US | claimed |
| US-4123400-A | B-DIKETONES, A POLYOL, ORGANO-METALLIC SALTS | RHONE-POULENC INDUSTRIES (FR) | 1978-10-31 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200361856-A1 | METHOD FOR PRODUCING ISOCYANATES | IDH2, ADH5, ADH1C | ACHE 929/4885NPC1 1740/4885RAB9A 2812/4885 |
| US-10858310-B1 | Method for producing isocyanates | IDH2, ADH5, ADH1C | ACHE 929/4885NPC1 1740/4885RAB9A 2812/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.